Plasma arginine vasopressin and motor activity in major depression.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biological Psychiatry

• Publication date

  1998-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0006-3223(97)80433-7PMID 9494701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EEG effects of subcutaneous and intracerebroventricular injections of arginine vasopressin in the rat

  2004cited by this paper
• Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

  1997cited by this paper
• The role of acetylcholine mechanisms in mood disorders

  1995cited by this paper
• Psychopharmacology: The Fourth Generation of Progress

  1995cited by this paper
• Circadian pattern of motor activity in major depressed patients undergoing antidepressant therapy: relationship between actigraphic measures and clinical course.

  1994cited by this paper
• Central nervous system effects of the neurohypophyseal hormones and related peptides.

  1993cited by this paper
• Effects of excitatory and inhibitory amino acids on neuronal discharges in the cultured suprachiasmatic nucleus.

  1993cited by this paper
• Effects of 28-day isolation (ESA-ISEMSI'90) on blood pressure and blood volume regulating hormones.

  1993cited by this paper
• Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.

  1993cited by this paper
• Homozygous Brattleboro rats display attenuated conditioned freezing responses.

  1993cited by this paper
• Vasopressin regulates human sleep by reducing rapid-eye-movement sleep.

  1992cited by this paper
• Psychomotor activity in unipolar and bipolar depressive patients.

  1992cited by this paper
• [Significance of studies of motor activity in depression].

  1992cited by this paper
• Solid-phase extraction of plasma vasopressin: evaluation, validation and application.

  1991cited by this paper
• Effects of chronic icv infusion of vasopressin on sleep-waking cycle of rats.

  1989cited by this paper
• Oxytocin: neurobiologic considerations and their implications for affective illness.

  1988cited by this paper
• Effects of enhanced cerebrospinal fluid levels of vasopressin, vasopressin antagonist or vasoactive intestinal polypeptide on circadian sleep-wake rhythm in the rat.

  1987cited by this paper
• Studies of vasopressin in the human cerebrospinal fluid

  1986cited by this paper
• Monitoring of Long-Term Motor Activity in Depressed Patients

  1986cited by this paper
• Release of oxytocin during suckling and parturition in the rat.

  1985cited by this paper
• Neurotransmitter regulation of anterior pituitary hormones.

  1985cited by this paper
• The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale.

  1984cited by this paper
• Psychomotor retardation: clinical, theoretical, and psychometric aspects.

  1983cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE

  1978cited by this paper
• Responses of neurons in the suprachiasmatic nuclei of the hypothalamus to putative transmitters.

  1977cited by this paper
• Psychomotor activity as a correlate of Depression and sleep in acutely disturbed psychiatric inpatients.

  1975cited by this paper
• Psychomotor activity as a correlate of Depression and sleep in acutely disturbed psychiatric inpatients.

  1975cited by this paper

• Neuropeptidergic systems in psychiatric disorders

  2026cites this paper
• Therapeutic Potential of Vasopressin in the Treatment of Neurological Disorders.

  2024cites this paper
• Relationship between postpartum depression and plasma vasopressin level at 6–8 weeks postpartum: a cross-sectional study

  2023cites this paper
• Oxytocin: An Old Hormone, A Novel Psychotropic Drug And Possible Use In Treating Psychiatric Disorders.

  2022cites this paper
• Psychoendocrinology: arginine vasopressin and resilience in patients with major depressive disorder

  2021cites this paper
• Sex differences in stress-related disorders: Major depressive disorder, bipolar disorder, and posttraumatic stress disorder.

  2020cites this paper
• Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study

  2020cites this paper
• Advances in novel molecular targets for antidepressants.

  2020cites this paper
• The relationship between oxytocin, vasopressin and atrial natriuretic peptide levels and cognitive functions in patients with schizophrenia

  2019cites this paper
• The Critical Overview and Provisions of a Survivor in the Depressive Condition

  2019cites this paper
• General discussion, conclusions

  2019cites this paper
• The endogenous oxytocin system in depressive disorders: A systematic review and meta-analysis.

  2019cites this paper
• Distinguishing Subgroups Based on Psychomotor Functioning among Patients with Major Depressive Disorder

  2018cites this paper
• The human hypothalamus in mood disorders: The HPA axis in the center

  2018cites this paper
• Major Depressive Disorder: Pathophysiology and Clinical Management.

  2017cites this paper
• Accelerated high-frequency repetitive transcranial magnetic stimulation enhances motor activity in rats.

  2017cites this paper
• Kendine zarar verme davranışı olan ergenlerde ve annelerinde bağlanma ve oksitosin, vazopressin düzeyleri

  2017influential citation
• Opposite effects of central oxytocin and arginine vasopressin on changes in gastric motor function induced by chronic stress

  2017cites this paper
• Vasopressinergic control of stress-related behavior: studies in Brattleboro rats

  2016cites this paper
• Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis.

  2016influential citation
• The Role of Vasopressin in Anxiety and Depression

  2016cites this paper
• Evaluation of the Antidepressant-like Activity of the Crude Extract and Solvent Fractions of Rosa Abyssinica Lindley (Rosaceae) Using Rodent Models of Depression

  2016cites this paper
• Restoration of peripheral V2 receptor vasopressin signaling fails to correct behavioral changes in Brattleboro rats.

  2015cites this paper
• Association between bipolar episodes and fluid and electrolyte homeostasis: a retrospective longitudinal study

  2014cites this paper
• Effects of photoperiod on food intake, activity and metabolic rate in adult neutered male cats.

  2014cites this paper
• Nouveau procédé diagnostique pour diagnostiquer la dépression et surveiller l'efficacité d'une thérapie

  2014cites this paper
• Oxytocin and Vasopressin in Children and Adolescents With Autism Spectrum Disorders: Sex Differences and Associations With Symptoms

  2013cites this paper
• Possible role of adrenomedullin and nitric oxide in major depression.

  2013cites this paper
• Title : The Role of Oxytocin in Psychiatric Disorders : A Review of Biological and Therapeutic Research Findings Activity

  2013cites this paper
• The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

  2013cites this paper
• Psychomotor Retardation in Depression: A Systematic Review of Diagnostic, Pathophysiologic, and Therapeutic Implications

  2013cites this paper
• Vasopressin V1a and V1b receptors: from molecules to physiological systems.

  2012cites this paper
• Emerging drugs for major depressive disorder: an update

  2012cites this paper
• A review of Atypical depression in relation to the course of depression and changes in HPA axis organization.

  2012cites this paper
• Effect of arginine vasopressin on the behavioral activity in the behavior despair depression rat model.

  2012cites this paper
• Neurotransmitters and neuropeptides in depression.

  2012cites this paper
• Sleep-Wake Cycle and Subjective Sleep Quality in Elderly Patients With Major Depression: an Actigraphy Study

  2011cites this paper
• Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

  2011cites this paper
• Support for two increased vasopressinergic activities in depression at large and the differential effect of antidepressant treatment

  2011cites this paper
• Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus.

  2010cites this paper
• Motor activity in depressed patients during therapeutic sleep deprivation

  2010cites this paper
• Sustained elevated levels of circulating vasopressin selectively stimulate the proliferation of kidney tubular cells via the activation of V2 receptors.

  2009cites this paper
• Depression and antidepressants: molecular and cellular aspects

  2009cites this paper
• Neuropeptides involved in the pathophysiology of schizophrenia and major depression

  2009cites this paper
• Postnatal expression of V2 vasopressin receptor splice variants in the rat cerebellum.

  2009cites this paper
• Oxytocin, vasopressin, and human social behavior.

  2009cites this paper
• Towards an improvement of the differentiation of depressive disorders. A multidimensional approach

  2009cites this paper
• New topics in vasopressin receptors and approach to novel drugs: role of the vasopressin receptor in psychological and cognitive functions.

  2009cites this paper
• Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.

  2008cites this paper
• Blockade of the V(1b) receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity.

  2008cites this paper
• The stress system in depression and neurodegeneration: focus on the human hypothalamus.

  2008cites this paper
• Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder.

  2008cites this paper
• Involvement of vasopressin in affective disorders.

  2008cites this paper
• Psychomotor symptoms in depression: a diagnostic, pathophysiological and therapeutic tool.

  2008cites this paper
• Behavioral and Brain Functions

  2007cites this paper
• Aggressive behavior linked to corticotropin-reactive autoantibodies.

  2006cites this paper
• The human hypothalamus in metabolic and episodic disorders.

  2006cites this paper
• Non-monoamine-based approach for the treatment of depression and anxiety disorders.

  2006cites this paper
• Depression with above-normal plasma vasopressin: validation by relations with family history of depression and mixed anxiety and retardation.

  2006cites this paper
• Modulation von Peptidrezeptoren

  2005cites this paper
• Impaired repression at a vasopressin promoter polymorphism in a rat model of trait anxiety and depression

  2005cites this paper
• The stress system in the human brain in depression and neurodegeneration.

  2005cites this paper
• The Neurobiology of Postpartum Depression

  2005cites this paper
• Promising new directions in antidepressant development

  2004cites this paper
• The role of actigraphy in the study of sleep and circadian rhythms.

  2003cites this paper
• Motor activity and autonomic cardiac functioning in major depressive disorder.

  2003cites this paper
• 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder.

  2002cites this paper
• The Neuroendocrinology of Affective Disorders

  2002cites this paper
• Vasopressin as a target for antidepressant development: an assessment of the available evidence.

  2002cites this paper
• Weak 24-h periodicity of body temperature and increased plasma vasopressin in melancholic depression.

  2001cites this paper
• Isokinetic Muscle Performance in Major Depressive Disorder: Alterations by Antidepressant Therapy

  2001cites this paper
• Isokinetic Muscle Performance in Major Depressive Disorder: Alterations by Antidepressant Therapy

  2001cites this paper
• Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression.

  2000cites this paper
• Depressive symptomatology and cocaine-induced pituitary-adrenal axis activation in individuals with cocaine dependence.

  1999cites this paper
• Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression

  1998cites this paper
• Three- to 5-year prospective follow-up of outcome in major depression

  1998cites this paper
• De regulatie van de hypothalamus-hypofyse-bijnier-as in de pathogenese van depressieve stoornissen

  1998cites this paper